Serum CA-125 tumor marker in endometrial adenocarcinoma. 2003

V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
Department of Gynecology and Obstetrics, Merkur University Hospital, Zagreb, Croatia.

One hundred and seventy-four patients, mean age 61.23 +/- 9.41 years old, with irregular perimenopausal haemorrhage were included in the study. Fractional curettage was performed in all patients. When the pathohistologic findings were adenocarcinoma the concentration of CA-125 tumor marker was determined. Hysterectomy with bilateral salpingo-oophorectomy was determined. In 142 cases carcinoma was restricted to the uterus and in 32 patients extrauterine metastatic disease was found. In the former group CA-125 was positive in 130 patients with a mean value of 64.12 +/- 22.41 U/ml serum. In the latter group the cancer antigen was positive in 29 patients with a mean value of 244.82 +/- 68.11 U/ml. High production is associated with increased metastatic potential.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015907 Hysteroscopy Endoscopic examination, therapy or surgery of the interior of the uterus. Endoscopy, Uterine,Hysteroscopic Surgical Procedures,Surgical Procedures, Hysteroscopic,Uterine Endoscopy,Hysteroscopic Surgery,Surgery, Hysteroscopic,Uteroscopy,Endoscopies, Uterine,Hysteroscopic Surgeries,Hysteroscopic Surgical Procedure,Hysteroscopies,Procedure, Hysteroscopic Surgical,Procedures, Hysteroscopic Surgical,Surgeries, Hysteroscopic,Surgical Procedure, Hysteroscopic,Uterine Endoscopies,Uteroscopies
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial
D018394 CA-125 Antigen A carbohydrate antigen that occurs in tumors of the ovary as well as in breast, kidney, and gastrointestinal tract tumors and normal tissue. While it is tumor-associated, it is not tumor-specific and may have a protective function against particles and infectious agents at mucosal surfaces. Antigen CA-125,CA 125 Antigen,Mucin-16,Antigen CA 125,Antigen, CA 125,Antigen, CA-125,Mucin 16

Related Publications

V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
June 1990, Gynecologic oncology,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
February 1994, Harefuah,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
August 1992, Acta obstetricia et gynecologica Scandinavica,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
January 1990, The Journal of nuclear medicine and allied sciences,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
June 1995, Schweizerische medizinische Wochenschrift,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
November 1986, American journal of obstetrics and gynecology,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
November 1987, La Radiologia medica,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
November 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
January 1999, European journal of gynaecological oncology,
V Kukura, and G Zovko, and S Ciglar, and L Markulin-Grgić, and F Santek, and M Podgajski, and Z Duić
December 1990, Minerva ginecologica,
Copied contents to your clipboard!